208 related articles for article (PubMed ID: 38581547)
1. Impact of genotype on multi-organ iron and complications in patients with non-transfusion-dependent β-thalassemia intermedia.
Meloni A; Pistoia L; Ricchi P; Bagnato S; Longo F; Messina G; Bagnato S; Rossi V; Renne S; Righi R; Fina P; Positano V; Cademartiri F
Ann Hematol; 2024 Jun; 103(6):1887-1896. PubMed ID: 38581547
[TBL] [Abstract][Full Text] [Related]
2. Link between Genotype and Multi-Organ Iron and Complications in Children with Transfusion-Dependent Thalassemia.
Meloni A; Pistoia L; Ricchi P; Putti MC; Gamberini MR; Cuccia L; Messina G; Massei F; Facchini E; Righi R; Renne S; Peritore G; Positano V; Cademartiri F
J Pers Med; 2022 Mar; 12(3):. PubMed ID: 35330400
[TBL] [Abstract][Full Text] [Related]
3. Multiparametric cardiac magnetic resonance in patients with thalassemia intermedia: new insights from the E-MIOT network.
Meloni A; Pistoia L; Ricchi P; Longo F; Cecinati V; Sorrentino F; Cuccia L; Corigliano E; Rossi V; Righi R; Fina P; Renne S; Barbuto L; Positano V; Cademartiri F
Radiol Med; 2024 Jun; 129(6):879-889. PubMed ID: 38683500
[TBL] [Abstract][Full Text] [Related]
4. Extramedullary hematopoiesis is associated with lower cardiac iron loading in chronically transfused thalassemia patients.
Ricchi P; Meloni A; Spasiano A; Neri MG; Gamberini MR; Cuccia L; Caruso V; Gerardi C; D'Ascola DG; Rosso R; Campisi S; Rizzo M; Terrazzino F; Vangosa AB; Chiodi E; Missere M; Mangione M; Positano V; Pepe A
Am J Hematol; 2015 Nov; 90(11):1008-12. PubMed ID: 26228763
[TBL] [Abstract][Full Text] [Related]
5. β-thalassemia intermedia: a clinical perspective.
Musallam KM; Taher AT; Rachmilewitz EA
Cold Spring Harb Perspect Med; 2012 Jul; 2(7):a013482. PubMed ID: 22762026
[TBL] [Abstract][Full Text] [Related]
6. Cardiac involvement by CMR in different genotypic groups of thalassemia major patients.
Pistoia L; Meloni A; Salvadori S; Spasiano A; Lisi R; Rosso R; Maggio A; D'Ascola DG; Cuccia L; Mangione M; Vallone A; Restaino G; Midiri M; Pepe A
Blood Cells Mol Dis; 2019 Jul; 77():1-7. PubMed ID: 30878912
[TBL] [Abstract][Full Text] [Related]
7. [Current management of thalassemia intermedia].
Thuret I
Transfus Clin Biol; 2014 Nov; 21(4-5):143-9. PubMed ID: 25282488
[TBL] [Abstract][Full Text] [Related]
8. Association between genotype and disease complications in Egyptian patients with beta thalassemia: A Cross-sectional study.
Hassan T; Zakaria M; Fathy M; Arafa M; El Gebaly S; Emam A; Abdel Wahab A; Shehab M; Salah H; Malek M; El Gerby K
Sci Rep; 2018 Dec; 8(1):17730. PubMed ID: 30531823
[TBL] [Abstract][Full Text] [Related]
9. Beta-Thalassemia Intermedia: A Single Thalassemia Center Experience from Northeastern Iraq.
Amin SS; Jalal SD; Ali KM; Mohammed AI; Rasool LK; Osman TJ
Biomed Res Int; 2020; 2020():2807120. PubMed ID: 32190657
[TBL] [Abstract][Full Text] [Related]
10. Final Height and Endocrine Complications in Patients with β-Thalassemia Intermedia: Our Experience in Non-Transfused Versus Infrequently Transfused Patients and Correlations with Liver Iron Content.
Yassin MA; Soliman AT; De Sanctis V; Yassin KS; Abdulla MA
Mediterr J Hematol Infect Dis; 2019; 11(1):e2019026. PubMed ID: 31205630
[TBL] [Abstract][Full Text] [Related]
11. Thalassemia intermedia: revisited.
Taher A; Isma'eel H; Cappellini MD
Blood Cells Mol Dis; 2006; 37(1):12-20. PubMed ID: 16737833
[TBL] [Abstract][Full Text] [Related]
12. Beta-thalassemia.
Galanello R; Origa R
Orphanet J Rare Dis; 2010 May; 5():11. PubMed ID: 20492708
[TBL] [Abstract][Full Text] [Related]
13. Glutathione S-transferase gene polymorphism: Relation to cardiac iron overload in Egyptian patients with Beta Thalassemia Major.
Mokhtar GM; Sherif EM; Habeeb NM; Abdelmaksoud AA; El-Ghoroury EA; Ibrahim AS; Hamed EM
Hematology; 2016 Jan; 21(1):46-53. PubMed ID: 26288192
[TBL] [Abstract][Full Text] [Related]
14. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
Chirico V; Rigoli L; Lacquaniti A; Salpietro V; Piraino B; Amorini M; Salpietro C; Arrigo T
Eur J Haematol; 2015 May; 94(5):404-12. PubMed ID: 25200112
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of extramedullary hematopoiesis, renal cysts, splenic and hepatic lesions, and vertebral hemangiomas among thalassemic patients: a retrospective study from the Myocardial Iron Overload in Thalassemia (MIOT) network.
Ricchi P; Meloni A; Grigoratos C; Toia P; Fina P; Pistoia L; Costantini S; Borsellino Z; Lisi R; Rocca M; Preziosi P; Midiri M; Pepe A
Ann Hematol; 2019 Jun; 98(6):1333-1339. PubMed ID: 30891614
[TBL] [Abstract][Full Text] [Related]
16. Pituitary iron and volume predict hypogonadism in transfusional iron overload.
Noetzli LJ; Panigrahy A; Mittelman SD; Hyderi A; Dongelyan A; Coates TD; Wood JC
Am J Hematol; 2012 Feb; 87(2):167-71. PubMed ID: 22213195
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cardiac and hepatic iron overload in thalassemia major patients with T2* magnetic resonance imaging.
Wahidiyat PA; Liauw F; Sekarsari D; Putriasih SA; Berdoukas V; Pennell DJ
Hematology; 2017 Sep; 22(8):501-507. PubMed ID: 28218005
[TBL] [Abstract][Full Text] [Related]
18. Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia.
Musallam KM; Cappellini MD; Wood JC; Motta I; Graziadei G; Tamim H; Taher AT
Haematologica; 2011 Nov; 96(11):1605-12. PubMed ID: 21791471
[TBL] [Abstract][Full Text] [Related]
19. Iron overload in non-transfusion-dependent thalassemia: association with genotype and clinical risk factors.
Tantiworawit A; Charoenkwan P; Hantrakool S; Choeyprasert W; Sivasomboon C; Sanguansermsri T
Int J Hematol; 2016 Jun; 103(6):643-8. PubMed ID: 27052211
[TBL] [Abstract][Full Text] [Related]
20. Guidelines for diagnosis and management of Beta-thalassemia intermedia.
Karimi M; Cohan N; De Sanctis V; Mallat NS; Taher A
Pediatr Hematol Oncol; 2014 Oct; 31(7):583-96. PubMed ID: 25247665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
